Moreover, atorvastatin did not mitigate liver fibrosis as evaluated by Sirius red liver staining and by the mRNA expression of fibrotic markers such as αSMA, Col1a1, and Tgfβ1 (Figure 2). Here, TGFB1 is linked to Hepatic fibrosis.